NewCardio Selling General Administrative vs Research Development Analysis

NewCardio financial indicator trend analysis is infinitely more than just investigating NewCardio recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NewCardio is a good investment. Please check the relationship between NewCardio Selling General Administrative and its Research Development accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewCardio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.

Selling General Administrative vs Research Development

Selling General Administrative vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NewCardio Selling General Administrative account and Research Development. At this time, the significance of the direction appears to have almost identical trend.
The correlation between NewCardio's Selling General Administrative and Research Development is 0.97. Overlapping area represents the amount of variation of Selling General Administrative that can explain the historical movement of Research Development in the same time period over historical financial statements of NewCardio, assuming nothing else is changed. The correlation between historical values of NewCardio's Selling General Administrative and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling General Administrative of NewCardio are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Selling General Administrative i.e., NewCardio's Selling General Administrative and Research Development go up and down completely randomly.

Correlation Coefficient

0.97
Relationship DirectionPositive 
Relationship StrengthVery Strong

Selling General Administrative

Research Development

Most indicators from NewCardio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NewCardio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewCardio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.The current Selling General Administrative is estimated to decrease to about 5.6 M. The NewCardio's current Enterprise Value Over EBITDA is estimated to increase to -3.11

NewCardio fundamental ratios Correlations

-0.98-0.930.960.940.960.980.940.98-1.0-0.95-0.291.0-0.95-0.92-1.00.03
-0.980.99-0.9-0.99-0.91-0.96-0.99-1.00.970.990.15-0.970.990.880.97-0.23
-0.930.99-0.83-1.0-0.83-0.91-1.0-0.980.911.00.03-0.921.00.810.91-0.39
0.96-0.9-0.830.861.00.980.840.92-0.95-0.87-0.260.97-0.87-0.84-0.95-0.18
0.94-0.99-1.00.860.860.940.990.99-0.91-1.00.00.93-1.0-0.79-0.910.34
0.96-0.91-0.831.00.860.980.840.92-0.95-0.87-0.260.97-0.87-0.84-0.95-0.18
0.98-0.96-0.910.980.940.980.910.97-0.96-0.94-0.140.98-0.94-0.83-0.95-0.01
0.94-0.99-1.00.840.990.840.910.98-0.93-1.0-0.090.93-1.0-0.84-0.930.36
0.98-1.0-0.980.920.990.920.970.98-0.96-0.99-0.110.97-0.99-0.85-0.960.21
-1.00.970.91-0.95-0.91-0.95-0.96-0.93-0.960.930.37-1.00.930.951.00.0
-0.950.991.0-0.87-1.0-0.87-0.94-1.0-0.990.930.06-0.941.00.830.93-0.32
-0.290.150.03-0.260.0-0.26-0.14-0.09-0.110.370.06-0.310.060.610.380.53
1.0-0.97-0.920.970.930.970.980.930.97-1.0-0.94-0.31-0.94-0.92-1.00.0
-0.950.991.0-0.87-1.0-0.87-0.94-1.0-0.990.931.00.06-0.940.830.93-0.32
-0.920.880.81-0.84-0.79-0.84-0.83-0.84-0.850.950.830.61-0.920.830.960.05
-1.00.970.91-0.95-0.91-0.95-0.95-0.93-0.961.00.930.38-1.00.930.96-0.01
0.03-0.23-0.39-0.180.34-0.18-0.010.360.210.0-0.320.530.0-0.320.05-0.01
Click cells to compare fundamentals

NewCardio Account Relationship Matchups

Currently Active Assets on Macroaxis

When determining whether NewCardio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NewCardio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Newcardio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Newcardio Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewCardio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewCardio. If investors know NewCardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NewCardio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.008
Quarterly Revenue Growth
(0.90)
Return On Assets
(2.24)
The market value of NewCardio is measured differently than its book value, which is the value of NewCardio that is recorded on the company's balance sheet. Investors also form their own opinion of NewCardio's value that differs from its market value or its book value, called intrinsic value, which is NewCardio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NewCardio's market value can be influenced by many factors that don't directly affect NewCardio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NewCardio's value and its price as these two are different measures arrived at by different means. Investors typically determine if NewCardio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NewCardio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.